I hesitate to even let the word ‘coronavirus’ roll off my tongue right now. We’re all bombarded with a daily barrage of conflicting information, opinions, and conspiracy theories – and it’s not my intention to add, needlessly, to the heap.

I should also mention that this isn’t a shameless profiteering campaign, designed to drive you into a paranoia-induced CBD/CBG shopping spree. Yes, we do absolutely carry CBG oil, and it’s fine with us if you’d like to purchase some. But, we simply thought the following information was very interesting, in addition to being timely and topical.

The info? It turns out cannabis (and industrial hemp) has a “hidden antibiotic potential.” This is according to a team at McMaster University in Canada. According to their study, the compound responsible for the antibiotic properties is none other than cannabigerol. Or, simply, CBG.

We recently did a blog post about this ‘up and coming’ compound – including what it is, and why you’re about to hear so much more about it. In that post, we mentioned these antibacterial properties. CBG is specifically known for its effectiveness in treating mice with methicillin-resistant Staphylococcus aureus (MRSA.) MRSA is notoriously resistant to many antibiotics.

The McMaster team reports that they isolated several different compounds from the cannabis plant. All of the compounds showed at least some antibiotic activity. Yet, CBG showed enough promise to shift their focus to this solitary compound. They add that CBG shows enough real therapeutic potential to further develop cannabinoids for the specific use as antibiotics.

As we mentioned in out CBG blog post last month, the emergence of this compound’s isolation comes from selective breeding of cannabis and hemp plants. In most strains, the level of cannabigerol is extremely low. But now that we’re starting to see potential benefits of this special compound, new strains are being developed with much higher levels.

We can only assume that we are on the cusp of a huge boom in demand for CBG, but never imagined that boom in popularity may come from the pharmaceutical industry.